Bayesian optimization design for finding a maximum tolerated dose combination in phase I clinical trials (Q6637076)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Bayesian optimization design for finding a maximum tolerated dose combination in phase I clinical trials |
scientific article; zbMATH DE number 7942972
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bayesian optimization design for finding a maximum tolerated dose combination in phase I clinical trials |
scientific article; zbMATH DE number 7942972 |
Statements
Bayesian optimization design for finding a maximum tolerated dose combination in phase I clinical trials (English)
0 references
13 November 2024
0 references
Bayesian optimization
0 references
combination therapy
0 references
maximum tolerated dose
0 references
nonparametric method
0 references
phase I clinical trials
0 references
0 references
